Virtual cocrystal screening
暂无分享,去创建一个
Christopher A. Hunter | Rafel Prohens | James F. McCabe | C. Hunter | J. McCabe | Daniele Musumeci | Daniele Musumeci | Serena Scuderi | Rafel Prohens | Serena Scuderi | R. Prohens
[1] William Jones,et al. Recent Advances in Understanding the Mechanism of Cocrystal Formation via Grinding , 2009 .
[2] M. Berthelot,et al. Can semi-empirical calculations yield reasonable estimates of hydrogen-bonding basicity? The case of nitriles , 1997 .
[3] S. Childs,et al. The role of solvent in mechanochemical and sonochemical cocrystal formation: a solubility-based approach for predicting cocrystallisation outcome , 2009 .
[4] J. McMahon,et al. Crystal engineering of the composition of pharmaceutical phases. , 2003, Chemical communications.
[5] Christer B Aakeröy,et al. Constructing, deconstructing, and reconstructing ternary supermolecules. , 2007, Chemical communications.
[6] M. Zaworotko,et al. Concomitant and Conformational Polymorphism, Conformational Isomorphism, and Phase Relationships in 4-Cyanopyridine·4,4‘-biphenol Cocrystals , 2006 .
[7] Geoff G. Z. Zhang,et al. Efficient co-crystal screening using solution-mediated phase transformation. , 2007, Journal of pharmaceutical sciences.
[8] W. D. Sam Motherwell,et al. The probable number of hydrogen-bonded contacts for chemical groups in organic crystal structures , 2004 .
[9] W. Motherwell,et al. Physical stability enhancement of theophylline via cocrystallization. , 2006, International journal of pharmaceutics.
[10] Gautam R. Desiraju,et al. Saccharin salts of active pharmaceutical ingredients, their crystal structures, and increased water solubilities , 2005 .
[11] Tejender S. Thakur,et al. Crystal Structure Prediction of a Co-Crystal Using a Supramolecular Synthon Approach: 2-Methylbenzoic Acid−2-Amino-4-methylpyrimidine , 2008 .
[12] Peddy Vishweshwar,et al. Pharmaceutical co-crystals. , 2006, Journal of pharmaceutical sciences.
[13] M. C. Etter,et al. The use of cocrystallization as a method of studying hydrogen bond preferences of 2-aminopyrimidine , 1990 .
[14] Richard W. Duerst,et al. Cocrystals of Caffeine and Hydroxybenzoic Acids Composed of Multiple Supramolecular Heterosynthons: Screening via Solution-Mediated Phase Transformation and Structural Characterization , 2009 .
[15] T. Friščić,et al. Screening for inclusion compounds and systematic construction of three-component solids by liquid-assisted grinding. , 2006, Angewandte Chemie.
[16] Raj Suryanarayanan,et al. A rapid thermal method for cocrystal screening , 2008 .
[17] Aeri Park,et al. Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API , 2006, Pharmaceutical Research.
[18] Christian Laurence,et al. Observations on the strength of hydrogen bonding , 2000 .
[19] William Jones,et al. Solvent-drop grinding: green polymorph control of cocrystallisation. , 2004, Chemical communications.
[20] C. Aakeröy,et al. Supramolecular reagents: versatile tools for non-covalent synthesis. , 2005, Chemical communications.
[21] Peter T. A. Galek,et al. Knowledge-based H-bond prediction to aid experimental polymorph screening , 2009 .
[22] Michael J Cima,et al. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. , 2004, Advanced drug delivery reviews.
[23] Keith Chadwick,et al. How does grinding produce co-crystals? Insights from the case of benzophenone and diphenylamine , 2007 .
[24] J. G. Vinter,et al. Solvent effects on hydrogen bonding. , 2007, Angewandte Chemie.
[25] R. Davey,et al. Making Co-crystals-The utility of ternary phase diagrams , 2007 .
[26] P. Karamertzanis,et al. Can the Formation of Pharmaceutical Cocrystals Be Computationally Predicted? I. Comparison of Lattice Energies , 2009 .
[27] Michael J. Zaworotko,et al. Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines? , 2004 .
[28] Alan R. Kennedy,et al. Targeted crystallisation of novel carbamazepine solvates based on a retrospective Random Forest classification , 2008 .
[29] K. Arora,et al. Hierarchy of Supramolecular Synthons: Persistent Carboxylic Acid···Pyridine Hydrogen Bonds in Cocrystals That also Contain a Hydroxyl Moiety , 2008 .
[30] Naír Rodríguez-Hornedo,et al. Analysis of 50 Crystal Structures Containing Carbamazepine Using the Materials Module of Mercury CSD , 2009 .
[31] Margaret C. Etter,et al. Hydrogen bonds as design elements in organic chemistry , 1991 .
[32] M. Berthelot,et al. HYDROGEN-BOND BASICITY PKHB SCALE OF SIX-MEMBERED AROMATIC N-HETEROCYCLES , 1998 .
[33] C. Hunter,et al. Quantifying intermolecular interactions: guidelines for the molecular recognition toolbox. , 2004, Angewandte Chemie.
[34] William Jones,et al. Pharmaceutical Cocrystallization: Engineering a Remedy for Caffeine Hydration , 2005 .
[35] David R. Weyna,et al. Hierarchy of supramolecular synthons: persistent hydroxyl...pyridine hydrogen bonds in cocrystals that contain a cyano acceptor. , 2007, Molecular pharmaceutics.
[36] Andrew V. Trask,et al. An overview of pharmaceutical cocrystals as intellectual property. , 2007, Molecular pharmaceutics.
[37] N. Rodríguez-Hornedo,et al. Screening strategies based on solubility and solution composition generate pharmaceutically acceptable cocrystals of carbamazepine , 2008 .